Acetylsalicylic acid Completed Phase 4 Trials for Type 2 Diabetes Mellitus / Coronary Artery Disease (CAD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01823510Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients
NCT02748330Platelet Inhibition of Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients After Elective Percutaneous Coronary Intervention